Epalrestat
Inquiry
| Post Date: | Nov 15,2013 |
| Expiry Date: | Nov 15,2014 |
| Detailed Description: |
Cas No. :82159-09-9
Epalrestat
CAS No. 82159-09-9 M. F. C15H13NO3S2 Molecular Weight: 319.401 Epalrestat inhibits Aldose Reductase (AR) involved in the rate limiting step in the conversion of glucose to sorbitol under hyperglycemic conditions. Aldose reductase has been the target of multiple clinical investigatons to treat diabetic neuropathy and retinopathy. Epalrestat is an approved drug in Japan and India, used for the treatment of diabetic neuropathy. ABATRA TECHNOLOGY CO., LTD s k y p e: abatra50 Room 203, Mei Ou Building, No. 4 Gaoxin-2 Road, Hi-Tech Development Zone, Xi'an, 710075, China |
| CAS Registry Number: | 82159-09-9 |
| Synonyms: | ;Epalrestat [INN];Ono 2235;5-((1Z,2E)-2-Methyl-3-phenylpropenylidene)-4-oxo-2-thioxo-3-thiazolidineacetic acid;5-((Z,E)-beta-Methylcinnamylidene)-4-oxo-2-thioxo-3-thiazolidineacetic acid;Epalrestatum;Epalrestatum [Latin];UNII-424DV0807X;3-Thiazolidineacetic acid, 5-(2-methyl-3-phenyl-2-propenylidene)-4-oxo-2-thioxo-, (E,E)-;{(5Z)-5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic acid;{(5E)-5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic acid;Kinedak; |
| Molecular Formula: | C15H13NO3S2 |
| Molecular Weight: | 319.3986 |
| Molecular Structure: | 
|
| Company: | ABATRA TECHNOLOGY CO., LTD [ China ] |
| Contact: | Nancy Gao |
| Tel: | 86-29-88313023 |
| Fax: | 86-29-88314556 |
| Email: | abatratech@yahoo.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
